Helixgate

Helixgate

Uncategorized

The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations

NEW YORK — Infant mortality in the U.S. dropped to a new all-time low in 2025, according to preliminary government data.

There were slightly fewer than 5.4 infant deaths per 1,000 live births in 2025, according to the Centers for Disease Control and Prevention.

Read the rest…

Read More

Published

on

NEW YORK — Infant mortality in the U.S. dropped to a new all-time low in 2025, according to preliminary government data.

There were slightly fewer than 5.4 infant deaths per 1,000 live births in 2025, according to the Centers for Disease Control and Prevention.

Read the rest…

Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short

Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short

Published

on

Although Edgewise Therapeutics’ hypertrophic cardiomyopathy asset missed expectations, Truist Securities called the data “excellent,” leaning on a safety profile that could eliminate the need for risk evaluation and mitigation strategies.​ ​Read More

Continue Reading

Uncategorized

Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more

Published

on

Moderna appears to have aligned with the FDA ahead of an advisory committee meeting for its mRNA-based flu vaccine, which the regulator initially turned away in February; biotech IPOs are going gangbusters, including two new records raises in as many weeks; layoffs continue across biopharma; plus much more.

Continue Reading

Uncategorized

PwC declares biopharma ecosystem ‘back to full health’ as M&A buoys sector

Published

on

Precision science is ruling the M&A scene as pharmas prepare for loss of exclusivity on key products, PwC says in a new report. Biotechs should be prepared with a dual-track process with the IPO window now open.

Continue Reading
Advertisement

Trending